Landscapes / Companies
CRISPR Therapeutics AG not checked
FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 in Phase 2
1 in Phase 1
Drugs
3
in active trials · 9 in all
Trials
4 active
11 since 2021
Drugs3
| Drug | How it works | Partner | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
— |
Phase 1/2 | 1 Jul 2028Phase 1/2 trial completes | |||
| Next date | 1 Jul 2028 · Phase 1/2 trial completes | ||||
| Also tested for | Hypertension | ||||
| Open drug page | |||||
— |
CRISPR Therapeutics |
Phase 1/2 | Jan 2030Phase 1/2 trial completes | ||
| Next date | Jan 2030 · Phase 1/2 trial completes | ||||
| Also tested for | B-cell Lymphoma, Non-Hodgkin Lymphoma and 10 more | ||||
| Open drug page | |||||
— |
Phase 1 | Jun 2027Phase 1 trial completes | |||
| Next date | Jun 2027 · Phase 1 trial completes | ||||
| Also tested for | Cardiovascular, Metabolic Disease and 8 more | ||||
| Open drug page | |||||
About
- No active trial
- 6 other drugs
- SEC filings
- None: it does not file with the US SEC
- Sources
- ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021